Copyright (c) 2009 Thomas Jefferson University All rights reserved. http://jdc.jefferson.edu/hplectures Recent documents in School of Population Health Lectures, Presentations, Workshops en-us Mon, 26 Oct 2009 11:10:21 PDT 3600 http://jdc.jefferson.edu/hplectures/7 http://jdc.jefferson.edu/hplectures/7 Fri, 23 Oct 2009 12:35:56 PDT Dr. Kate Lorig is the Director of the Stanford Patient Education Research Center.Dr. Kate Lorig, creator of the internationally recognized Chronic Disease Self Management Program (CDSMP), provided an overview of chronic disease prevention, treatment and management programs. She described the history and development of the evidence-based CDSMP and its research, policy implications, and program examples. This Seminar was followed by a lively discussion panel including; Molly A. Rose, PhD, RN, Jefferson School of Nursing; Michael P. Rosenthal, MD, Jefferson Medical College - Family & Community Medicine; and Lynn Fields Harris, MPA, Center in the Park. The event was co-sponsored by: Jefferson School of Population Health, Jefferson School of Nursing, Jefferson Medical College - Department of Family & Community Medicine, Jefferson School of Health Professions, Jefferson Center for Applied Research on Aging and Health (CARAH), and Jefferson InterProfessional Education Center (JCIPE).Presentation: 52 minutes Kate Lorig, RN, DrPH http://jdc.jefferson.edu/hplectures/6 http://jdc.jefferson.edu/hplectures/6 Mon, 11 May 2009 09:20:34 PDT The 18th Annual Raymond C. Grandon lecture was presented by Thomas J. Nasca, MD, MACP, Executive Director and CEO Accreditation Council for Graduate Medical Education (ACGME), on May 7, 2009 at Thomas Jefferson University, Philadelphia PA, USA.2 hours and 14 minutes. Thomas J. Nasca, MD, MACP http://jdc.jefferson.edu/hplectures/5 http://jdc.jefferson.edu/hplectures/5 Fri, 04 Jan 2008 10:43:46 PST Objective: To understand how patients with chronic non-cancer pain define and describe pain flares. L. T. Pizzi http://jdc.jefferson.edu/hplectures/4 http://jdc.jefferson.edu/hplectures/4 Fri, 04 Jan 2008 10:43:45 PST Purpose: One third of hemodialysis patients have high serum ferritin levels and low transferrin saturation (TSAT). The purpose of this analysis was to determine the cost effectiveness of administering 1g of sodium ferric gluconate complex (SFGC: also referred to as ferric gluconate) to patients with serum ferritin >500ng/mL and TSAT ≤25% based on the Dialysis Patients Response to IV Iron with Elevated Ferritin (DRIVE) study and its 6-week observational extension (DRIVE-II). In these studies, IV iron administration resulted in reduced epoetin requirements. Methods: Decision analysis was performed using a time horizon of 12 weeks, consistent with the combined duration of DRIVE and DRIVE II. Treatment effectiveness was based on mean increase in hemoglobin (Hb) for each group (SFGC plus epoetin or epoetin alone) in the intention to treat populations. Costs included drugs (SFGC and epoetin) and hospitalizations due to serious adverse events (SAEs) reported. The primary cost effectiveness measure was cost per g/dL of Hb increase at 12 weeks. Costs were computed from a Medicare perspective using projected 2007 reimbursements. Sensitivity analyses were performed to test the impact of using the safety population, median epoetin and SFGC doses, actual 2005 Medicare reimbursements, median increases in Hb, and SAE rate changes. The model was constructed using TreeAge Pro software. Results: Total cost per patient receiving SFGC plus epoetin was $3675 per g/dL Hb increase, while the total cost per patient receiving epoetin alone was $5065 per g/dL Hb increase. Net savings for SFGC plus epoetin was $1390 per g/dL Hb increase over the 12 week period Sensitivity analyses affirmed the robustness of the model. Conclusion: Administering 1g of SFGC plus epoetin in patients with high ferritin and low TSAT as defined in the DRIVE studies resulted in significant cost-savings compared to epoetin alone. Laura T. Pizzi http://jdc.jefferson.edu/hplectures/3 http://jdc.jefferson.edu/hplectures/3 Fri, 04 Jan 2008 10:43:43 PST Objectives Primary: To capture healthcare resource consumption and work loss in a population of patients with chronic pain who have pain flares from one or more non-cancer conditions. Secondary: To explore the relationship between anxiety, depression, and pain in this population. L. T. Pizzi http://jdc.jefferson.edu/hplectures/2 http://jdc.jefferson.edu/hplectures/2 Thu, 24 May 2007 12:40:56 PDT John G. Reiling, PhD, MHA, MBA, the President and CEO of Safe by Design presented the 16th Annual Dr. Raymond C. Grandon Lecture on May 3, 2007 at Jefferson Medical College. The podcast of Dr. Reiling's presentation entitled Patient Safety: The Impact of Facility Deisgn can be accessed by following the link. John G. Reiling http://jdc.jefferson.edu/hplectures/1 http://jdc.jefferson.edu/hplectures/1 Fri, 06 Apr 2007 05:40:50 PDT The Health Forum and the American Hospital Association's annual Leadership Summit for 2006, held in San Francisco, CA, featured a session including a video about emergency response following Hurricane Katrina, remarks by Gary Mecklenburg, and "Stragetic Health Perspectives" by Ian Morrison. Morrison's address was followed by a panel led by David B. Nash, MD, MBA, discussing "how we are doing with measuring and improving the quality of health care." Panel participants included Steven Mayfield (AHA), George Halvorson (Kaiser Permanente), James Conway (Institute for Healthcare Improvement and Dana Farber Cancer Center), and Carolyn Clancy (Agency for Healthcare Research and Quality). American Hospital Association